Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept for Immunosuppression in Hand Transplantation
NCT02310867Phase 2Recruiting
- Start
- Mar 2015
- Primary completion
- Dec 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in graft rejection. Started Mar 2015; status: recruiting.
02
Drugs
belatacept
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT02310867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310867.